Steven Cohen's IMCR Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.1 M shares of Immunocore Holdings plc (IMCR) worth $33.23 M, representing 0.04% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in IMCR, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 598,120 shares. Largest reduction occurred in Q2 2022, reducing 407,058 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Immunocore Holdings plc (IMCR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Immunocore Holdings plc (IMCR) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +598,120 | Add 118.64% | 1.1 M | $30.15 |
| Q4 2025 | -31,680 | Reduce 5.91% | 504,151 | $34.71 |
| Q3 2025 | -284,594 | Reduce 34.69% | 535,831 | $36.33 |
| Q2 2025 | +192,133 | Add 30.58% | 820,425 | $31.38 |
| Q1 2025 | +224,988 | Add 55.79% | 628,292 | $29.67 |
| Q4 2024 | +403,304 | New Buy | 403,304 | $29.50 |
| Q2 2022 | -407,058 | Sold Out | 0 | $0.00 |
| Q1 2022 | +394,658 | Add 3182.73% | 407,058 | $29.90 |
| Q4 2021 | -136,600 | Reduce 91.68% | 12,400 | $34.27 |
| Q3 2021 | +76,100 | Add 104.39% | 149,000 | $37.07 |
| Q2 2021 | +72,900 | New Buy | 72,900 | $39.05 |
Steven Cohen's Immunocore Holdings plc Investment FAQs
Steven Cohen first purchased Immunocore Holdings plc (IMCR) in Q2 2021, acquiring 72,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Immunocore Holdings plc (IMCR) for 11 quarters since Q2 2021.
Steven Cohen's largest addition to Immunocore Holdings plc (IMCR) was in Q1 2026, adding 1,102,271 shares worth $33.23 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,102,271 shares of Immunocore Holdings plc (IMCR), valued at approximately $33.23 M.
As of the Q1 2026 filing, Immunocore Holdings plc (IMCR) represents approximately 0.04% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Immunocore Holdings plc (IMCR) was 1,102,271 shares, as reported at the end of Q1 2026.